Page last updated: 2024-08-23

cefoperazone and minocycline

cefoperazone has been researched along with minocycline in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (14.29)18.2507
2000's4 (19.05)29.6817
2010's14 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Arpin, C; Fournier, M; Gagné, S; Hernould, M; Quentin, C1
Lombardo, F; Obach, RS; Waters, NJ1
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hara, K; Higashiyama, Y; Koga, H; Kohno, S; Maesaki, S; Matsuda, H; Mitsutake, K; Miyazaki, Y; Yamada, H; Yoshitomi, Y1
Chang, JC; Ho, SW; Hsieh, WC; Hsueh, PR; Luh, KT; Wu, JJ1
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H1
Akachi, S; Kondo, M; Kurokawa, I; Nishii, M; Yamanaka, K1
Mao, Y; Pei, G; Sun, Y1
Du, W; Liu, Y; Rui, X; Shi, Y; Wang, Y; Xu, YC1
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y1
Chen, X; Du, W; Ning, F; Rong, Y; Shen, Y; Wang, C; Wen, C; Zhang, G; Zhao, X1
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y1
Li, HX; Li, TZ; Wang, LW; Zou, L1
Bai, Y; Di, X; Liu, B; Liu, Y; Wang, J; Wang, R; Zhang, X1
Li, P; Wang, W; Wang, X; Zhao, X1
Gao, L; Li, Y; Lyu, Y1
Fu, L; Qin, Y; Wu, L; Xue, X; Zhang, D; Zhang, J1

Reviews

1 review(s) available for cefoperazone and minocycline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for cefoperazone and minocycline

ArticleYear
Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
    International journal of clinical pharmacology and therapeutics, 2018, Volume: 56, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Prospective Studies; Sulbactam; Tigecycline; Treatment Outcome

2018

Other Studies

19 other study(ies) available for cefoperazone and minocycline

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Dipeptides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Susceptibilities of 23 Desulfovibrio isolates from humans.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:7

    Topics: Aged; Cefoperazone; Corynebacterium; Corynebacterium Infections; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Minocycline; Opportunistic Infections; Pneumonia; Pneumonia, Staphylococcal; Sulbactam

1992
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Diffusion; Flavobacterium; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Piperacillin

1997
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:7

    Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins

1998
Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus?
    International journal of dermatology, 2010, Volume: 49, Issue:12

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cholecystitis, Acute; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Liver Failure, Acute; Minocycline; Polymerase Chain Reaction; Rickettsia; Rickettsia Infections; Sulbactam

2010
In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Sulbactam

2012
[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
    Zhonghua yi xue za zhi, 2012, Oct-30, Volume: 92, Issue:40

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Cefoperazone; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Prospective Studies; Sulbactam

2012
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    The Journal of international medical research, 2013, Volume: 41, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline

2013
A combination regimen of meropenem, cefoperazone-sulbactam and minocycline for extensive burns with pan-drug resistant Acinetobacter baumannii infection.
    Chinese medical journal, 2014, Volume: 127, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Burns; Cefoperazone; Humans; Meropenem; Middle Aged; Minocycline; Retrospective Studies; Sulbactam; Thienamycins; Young Adult

2014
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 23

    Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins

2014
[Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2014, Volume: 36, Issue:2

    Topics: Acinetobacter baumannii; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome

2014
In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Journal of chemotherapy (Florence, Italy), 2015, Volume: 27, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline

2015
Comparison of the efficacies of three empirically-selected antibiotics for treating Acinetobacter baumannii pulmonary infection: experience from a teaching hospital in China

.
    International journal of clinical pharmacology and therapeutics, 2017, Volume: 55, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefoperazone; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Minocycline; Respiratory Tract Infections; Retrospective Studies; Sputum; Sulbactam; Tigecycline; Time Factors; Treatment Outcome

2017
Trends in Drug Resistance of
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2017